北陆药业
(300016)
| 流通市值：63.29亿 | | | 总市值：63.38亿 |
| 流通股本：5.62亿 | | | 总股本：5.63亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 282,680,687.56 | 983,554,462.55 | 729,717,058.01 | 473,930,074.54 |
| 营业收入 | 282,680,687.56 | 983,554,462.55 | 729,717,058.01 | 473,930,074.54 |
| 二、营业总成本 | 270,747,397.37 | 980,948,906.19 | 705,505,413.93 | 452,058,612.63 |
| 营业成本 | 154,191,274.58 | 514,658,184.71 | 364,595,629.66 | 233,585,002.93 |
| 税金及附加 | 3,650,421.65 | 12,927,131.99 | 9,244,813.93 | 6,172,201.64 |
| 销售费用 | 56,669,317.32 | 243,347,360.61 | 177,551,992.89 | 112,925,510.32 |
| 管理费用 | 21,021,513.46 | 88,864,434.71 | 61,030,989.95 | 39,154,275.48 |
| 研发费用 | 21,400,376.2 | 69,238,085.8 | 53,171,942.94 | 35,451,885.44 |
| 财务费用 | 13,814,494.16 | 51,913,708.37 | 39,910,044.56 | 24,769,736.82 |
| 其中:利息费用 | 15,135,666.42 | 58,006,849.73 | 44,025,789.99 | 28,159,654.2 |
| 其中:利息收入 | 1,785,843.99 | 5,376,249.14 | 4,479,201.24 | 3,386,843.34 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 89,000.21 | -11,947,472.65 | -13,453,704.36 | -8,906,725.89 |
| 加:投资收益 | 1,940,075.2 | 7,358,221.99 | 5,746,021.26 | 3,779,391.65 |
| 资产处置收益 | -1,269,354.01 | 122,937.98 | 1,818.3 | 1,818.3 |
| 资产减值损失(新) | -813,005.1 | -9,929,441.71 | -3,782,649.19 | -3,221,910.06 |
| 信用减值损失(新) | 963,459.86 | 664,247.84 | 1,992,546.25 | 566,922.02 |
| 其他收益 | 2,818,198.99 | 10,530,122.3 | 8,187,909.05 | 6,510,135.74 |
| 四、营业利润 | 15,661,665.34 | -595,827.89 | 22,903,585.39 | 20,601,093.67 |
| 加:营业外收入 | 152,189.02 | 1,637,862.01 | 566,850.65 | 100,532.12 |
| 减:营业外支出 | 187,517.13 | 1,825,917.85 | 1,395,205.72 | 266,214.16 |
| 五、利润总额 | 15,626,337.23 | -783,883.73 | 22,075,230.32 | 20,435,411.63 |
| 减:所得税费用 | 2,324,017.11 | -1,051,535.54 | 3,071,597.96 | 5,235,740.4 |
| 六、净利润 | 13,302,320.12 | 267,651.81 | 19,003,632.36 | 15,199,671.23 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 13,302,320.12 | 267,651.81 | 19,003,632.36 | 15,199,671.23 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 14,538,525.05 | 13,651,677.43 | 24,394,304.8 | 19,541,206.25 |
| 少数股东损益 | -1,236,204.93 | -13,384,025.62 | -5,390,672.44 | -4,341,535.02 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.03 | 0.03 | 0.05 | 0.04 |
| (二)稀释每股收益 | 0.05 | 0.09 | 0.1 | 0.07 |
| 九、综合收益总额 | 13,302,320.12 | 267,651.81 | 19,003,632.36 | 15,199,671.23 |
| 归属于母公司股东的综合收益总额 | 14,538,525.05 | 13,651,677.43 | 24,394,304.8 | 19,541,206.25 |
| 归属于少数股东的综合收益总额 | -1,236,204.93 | -13,384,025.62 | -5,390,672.44 | -4,341,535.02 |
| 公告日期 | 2025-04-25 | 2025-04-18 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |